Mesabi Trust (MSB) Key Metrics

NYSE: MSBValuation, returns, debt and efficiency ratios over 10 years.

MSB valuation today

Trailing 12 months · as of October 18, 2026
Market cap
$234.6M
Enterprise value
$254.6M
P/E (TTM)
36.5
10-yr median 11.6
Forward P/E
12.8
PEG ratio
—
Price / sales
19.7
10-yr median 11.7
Price / book
15.5
10-yr median 20.5
EV / EBITDA
32.9
10-yr median 10.3
Dividend yield
4.98%
$0.89 a year
Beta
0.33

MSB key metrics, FY2017–FY2026

Fiscal year ended January 31, 2026 · U.S. dollars

MSB valuation Price multiples at each fiscal year-end price.

P/E ratio+837.6%
31.1
FY2026 · hover or tap a bar for each year
FY2017: 18.7 (+177.2%)FY2018: 9.7 (−48.0%)FY2019: 7.9 (−18.7%)FY2020: 8.9 (+12.7%)FY2021: 14.0 (+56.6%)FY2022: 5.3 (−61.7%)FY2023: 56.9 (+966.1%)FY2024: 13.5 (−76.3%)FY2025: 3.3 (−75.4%)FY2026: 31.1 (+837.6%)
FY2017FY2026
Price / sales+102.5%
24.6
FY2026 · hover or tap a bar for each year
FY2017: 16.5 (+178.0%)FY2018: 9.4 (−42.9%)FY2019: 7.6 (−19.3%)FY2020: 8.4 (+10.0%)FY2021: 12.6 (+50.3%)FY2022: 5.1 (−59.2%)FY2023: 39.0 (+659.7%)FY2024: 11.2 (−71.3%)FY2025: 12.2 (+8.6%)FY2026: 24.6 (+102.5%)
FY2017FY2026
Price / book+59.4%
21.2
FY2026 · hover or tap a bar for each year
FY2017: 17.6 (+174.3%)FY2018: 31.0 (+75.8%)FY2019: 21.4 (−30.8%)FY2020: 22.6 (+5.7%)FY2021: 19.8 (−12.4%)FY2022: 11.9 (−39.9%)FY2023: 26.4 (+121.6%)FY2024: 12.2 (−53.8%)FY2025: 13.3 (+8.8%)FY2026: 21.2 (+59.4%)
FY2017FY2026
EV / EBITDA+1,211.8%
29.5
FY2026 · hover or tap a bar for each year
FY2017: 16.7 (+192.7%)FY2018: 9.1 (−45.6%)FY2019: 7.2 (−20.6%)FY2020: 7.6 (+6.0%)FY2021: 11.6 (+51.9%)FY2022: 4.6 (−60.6%)FY2023: 38.2 (+736.5%)FY2024: 12.6 (−67.0%)FY2025: 2.2 (−82.2%)FY2026: 29.5 (+1,211.8%)
FY2017FY2026
Price / free cash flow+809.1%
30.0
FY2026 · hover or tap a bar for each year
FY2017: 14.3 (+103.4%)FY2018: 11.0 (−22.8%)FY2019: 7.9 (−28.2%)FY2020: 7.7 (−2.2%)FY2021: 15.7 (+102.7%)FY2022: 5.8 (−62.8%)FY2023: 21.8 (+273.1%)FY2024: 17.5 (−19.6%)FY2025: 3.3 (−81.2%)FY2026: 30.0 (+809.1%)
FY2017FY2026
Free cash flow yield−27.0 pts
3.3%
FY2026 · hover or tap a bar for each year
FY2017: 7.0% (−7.2 pts)FY2018: 9.1% (+2.1 pts)FY2019: 12.6% (+3.6 pts)FY2020: 12.9% (+0.3 pts)FY2021: 6.4% (−6.5 pts)FY2022: 17.1% (+10.7 pts)FY2023: 4.6% (−12.5 pts)FY2024: 5.7% (+1.1 pts)FY2025: 30.3% (+24.6 pts)FY2026: 3.3% (−27.0 pts)
FY2017FY2026

MSB valuation history

Fiscal year-endToday10-year median

MSB returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

MSB debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

MSB cash returned to shareholders

DividendsBuybacksFree cash flow

MSB price vs earnings per share

Share price at year-endEPS (right axis)

MSB key metrics

FY2017–FY2026
Mesabi Trust key metrics by fiscal year
FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Valuation
Market capitalization$431.6M$309.6M$256.0M$302.2M$367.1M$326.6M$267.8M$360.0M$325.4M$179.7M
Enterprise value$408.5M$209.4M$234.0M$288.2M$324.0M$304.4M$244.3M$329.4M$303.3M$165.6M
P/E ratio31.13.313.556.95.314.08.97.99.718.7
Price / sales24.612.211.239.05.112.68.47.69.416.5
Price / book21.213.312.226.411.919.822.621.431.017.6
Price / free cash flow30.03.317.521.85.815.77.77.911.014.3
Price / operating cash flow30.03.317.521.85.815.77.77.911.014.3
EV / sales23.38.210.237.24.511.77.67.08.815.2
EV / EBITDA29.52.212.638.24.611.67.67.29.116.7
EV / free cash flow28.42.216.020.85.214.67.17.210.313.2
Earnings yield3.2%30.1%7.4%1.8%18.7%7.2%11.2%12.7%10.3%5.3%
Free cash flow yield3.3%30.3%5.7%4.6%17.1%6.4%12.9%12.6%9.1%7.0%
Dividend yield21.2%5.7%1.8%15.8%10.2%6.7%16.5%10.2%6.0%4.0%
Shareholder yield (dividends + buybacks)21.2%5.7%1.8%15.8%10.2%6.7%16.5%10.2%6.0%4.0%
Share price at fiscal year-end$32.90$23.60$19.51$23.03$27.98$24.89$20.41$27.44$24.80$13.70
Per share
Revenue per share$1.34$1.94$1.74$0.59$5.45$1.98$2.44$3.60$2.63$0.83
Earnings per share$1.06$7.11$1.45$0.40$5.24$1.78$2.29$3.47$2.55$0.73
Operating cash flow per share$1.10$7.16$1.11$1.06$4.79$1.59$2.64$3.47$2.25$0.96
Free cash flow per share$1.10$7.16$1.11$1.06$4.79$1.59$2.64$3.47$2.25$0.96
Cash per share$1.77$7.64$1.83$1.06$3.64$1.71$1.79$2.52$1.84$1.08
Book value per share$1.56$1.78$1.60$0.87$2.35$1.26$0.90$1.28$0.80$0.78
Tangible book value per share$1.56$1.78$1.60$0.87$2.35$1.26$0.90$1.28$0.80$0.78
Dividends per share$6.97$1.35$0.35$3.63$2.86$1.67$3.36$2.79$1.49$0.55
Capex per share$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Debt per share—$0.00$0.15$0.00$0.35$0.02$0.01$0.18$0.16$0.00
Shares outstanding13.1M13.1M13.1M13.1M13.1M13.1M13.1M13.1M13.1M13.1M
Change in shares outstanding+0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Returns & profitability
Return on equity (ROE)63.4%421.1%117.1%25.1%290.9%165.4%209.9%333.6%323.4%100.2%
Return on assets (ROA)22.0%145.3%93.0%15.6%179.0%100.5%101.7%148.0%165.9%79.9%
Return on tangible assets56.9%91.7%71.1%37.6%127.5%102.1%127.1%128.5%128.2%67.5%
Free cash flow margin82.2%369.0%63.9%179.1%87.9%80.2%108.1%96.2%85.5%115.6%
Income quality (OCF / net income)1.041.010.772.610.910.891.151.000.881.31
Financial health
Total debt—$0$2.0M$23,562$4.6M$249,477$69,588$2.4M$2.1M$45,045
Cash & short-term investments$23.2M$100.2M$24.0M$14.0M$47.7M$22.4M$23.5M$33.0M$24.1M$14.2M
Net debt−$23.2M−$100.2M−$22.0M−$13.9M−$43.1M−$22.2M−$23.4M−$30.6M−$22.1M−$14.1M
Debt / equity—0.000.090.000.150.020.010.140.200.00
Debt / assets—0.000.070.000.090.010.000.070.080.00
Net debt / EBITDA−1.67−1.07−1.19−1.85−0.61−0.84−0.73−0.67−0.66−1.42
Current ratio6.161.304.6737.062.333.552.541.901.677.33
Quick ratio6.161.304.670.062.330.040.011.901.677.33
Interest coverage————152.3—443.1699.3——
Working capital$20.4M$23.3M$21.0M$13.7M$30.8M$16.5M$14.3M$16.8M$10.5M$12.3M
Invested capital−$2.8M−$76.9M−$1.0M−$2.5M−$12.3M−$5.7M−$11.6M−$13.8M−$11.5M−$3.9M
Tangible asset value$20.4M$23.3M$21.0M$11.4M$30.8M$16.5M$11.8M$16.8M$10.5M$10.2M
Net current asset value$20.4M$23.3M$21.0M$11.4M$30.8M$16.5M$11.8M$16.8M$10.5M$10.2M
Graham number$6.08$16.86$7.21$2.82$16.64$7.10$6.82$10.00$6.78$3.58
Graham net-net per share$1.52$1.74$1.53$1.40$2.22$2.10$1.79$1.23$0.76$0.77
Capital allocation
Dividends paid$91.4M$17.7M$4.6M$47.6M$37.5M$21.9M$44.1M$36.6M$19.5M$7.2M
Share buybacks (net)————————$0$0
Dividend payout ratio659.4%19.0%24.2%897.1%54.6%93.6%146.7%80.3%58.4%75.1%
Dividends + buybacks / free cash flow634.8%18.9%31.4%343.5%59.7%105.3%127.4%80.5%66.2%57.3%
Capex / revenue0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Capex / operating cash flow0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Capex / depreciation———0.000.000.000.000.000.000.00
R&D / revenue——0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
SG&A / revenue16.7%19.5%16.6%26.8%3.3%8.8%5.8%3.5%2.9%9.8%
Efficiency
Days sales outstanding25.527.319.4143.516.63.514.116.810.617.2
Days of inventory on hand———6,418.214,214.239,197.831,703.5———
Days payables outstanding———10,701.518,533.113,351.918,793.318,720.815,443.42,680.4
Cash conversion cycle (days)———-4,139.8-4,302.325,849.412,924.3-18,704.0-15,432.8-2,663.3
Receivables turnover14.3213.3518.772.5422.02104.5725.9621.7434.4821.28
Payables turnover———0.030.020.030.020.020.020.14
Inventory turnover———0.060.030.010.01———
Asset turnover0.280.401.120.231.861.111.081.541.710.90
Average receivables$1.2M$1.9M$1.2M$3.0M$3.2M$248,158$1.2M$2.2M$1.0M$511,596
Average payables———$11.7M$14.8M$7.9M$14.0M$17.1M$8.8M$1.4M
Average inventory———$7.0M$11.3M$23.1M$23.6M—$0$0
Intangibles / total assets0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Computed from MSB's annual financial statements (latest annual report filed April 22, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

MSB valuation and financial ratios

At the end of fiscal 2026 (January 31, 2026), Mesabi traded at 31.1 times earnings, against a 10-year median of 11.6. Based on the latest twelve months, the trailing P/E is 36.5 and the forward P/E is 12.8. Mesabi earned a return on equity of 63.4% in fiscal 2026. It returned $91.4 million to shareholders: $91.4 million in dividends and $0 in share buybacks, 635% of free cash flow.

See the MSB income statement, the MSB chart for price history, or the MSB stock overview for the latest quote and news.

MSB key metrics FAQ

What is Mesabi's P/E ratio?

Mesabi's trailing P/E ratio is 36.5 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 12.8. At the end of fiscal 2026 it was 31.1, compared with a 10-year median of 11.6.

What is Mesabi's EV/EBITDA?

Mesabi's enterprise value was 29.5 times EBITDA at the end of fiscal 2026 (enterprise value $408.5 million, EBITDA $13.9 million); the current EV/EBITDA is 32.9.

What is Mesabi's return on equity?

Mesabi's return on equity (ROE) was 63.4% in fiscal 2026: net income of $13.9 million on average shareholders' equity of $21.9 million.

What is Mesabi's dividend yield?

Mesabi's forward dividend yield is 4.98%. Mesabi paid $91.4 million in dividends in fiscal 2026 ($6.97 per share), a payout ratio of 659.4%.

What is Mesabi's free cash flow yield?

Mesabi generated $14.4 million of free cash flow in fiscal 2026, a free cash flow yield of 3.3% on its market value at year-end ($431.6 million).

What is Mesabi's current ratio?

Mesabi's current ratio was 6.16 at the end of fiscal 2026: current assets were 6.16 times current liabilities.

Steel key metrics